808769-14-4

Usage

Chemical class

Amphetamine

Molecular structure

Contains a bromine atom attached to a phenyl ring, a methyl group, and a propan-2-amine side chain

Functionality

Stimulant

Psychoactive effects

Acts on the central nervous system

Recreational use

Illicitly used as a recreational drug

Health risks

Potential for addiction and adverse physical and psychological effects

Legal status

Use is often controlled or prohibited in many jurisdictions due to its psychoactive properties and potential for harm

Upstream product

• 808769-15-5 N-[2-(3-bromophenyl)-1,1-dimethylethyl]-2-chloroacetamide 
• 21906-32-1 3-bromophenylacetone 
• 3762-39-8 1-(3-bromophenyl)-2-methylpropan-2-ol 
• 64781-38-0 1-bromo-3-(2-methylprop-1-en-1-yl)benzene 

Downstream Products

• 862540-70-3 N-[2-(benzyloxy)-5-((1R)-2-{[2-(3-bromophenyl)-1,1-dimethylethyl]amino}-1-hydroxyethyl)phenyl]methanesulfonamide 
• 808769-12-2 3-(2-tert-butoxycarbonylamino-2-methylpropyl)benzoic acid methyl ester 
• 808769-11-1 methyl 3-(2-amino-2-methylpropyl)benzoate 

Relevant academic research and scientific papers

Direct Access to Primary Amines from Alkenes by Selective Metal-Free Hydroamination

Direct and selective synthesis of primary amines from easily available precursors is attractive yet challenging. Herein, we report the rapid synthesis of primary amines from alkenes via metal-free regioselective hydroamination at room temperature. Ammonium carbonate was used as ammonia surrogate for the first time, allowing for efficient conversion of terminal and internal alkenes into linear, α-branched, and α-tertiary primary amines under mild conditions. This method provides a straightforward and powerful approach to a wide spectrum of advanced, highly functionalized primary amines which are of particular interest in pharmaceutical chemistry and other areas.

COMPOUNDS FOR THE TREATMENT OF DISEASES

The invention relates to compounds of formula (1) and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such derivatives. The compounds according to the present invention are useful in

FORMAMIDE DERIVATIVES USEFUL AS ADRENOCEPTOR

The invention relates to compounds of formula (1) and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such derivatives. The compounds according to the present invention are useful in numerous diseases, disorders and conditions, in particular inflammatory, allergic and respiratory diseases, disorders and conditions.

COMPOUNDS HAVING BETA-AGONIST ACTIVITY

The invention relates to compounds of formula (1) and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such derivatives. The compounds according to the present invention are useful in numerous diseases, disorders and conditions, in particular inflammatory, allergic and respiratory diseases, disorders and conditions.

Sulfonamide derivatives for the treatment of diseases

The invention relates to compounds of formula (1) and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such derivatives. The compounds according to the present invention are useful in

Phenylethanolamine derivatives as beta-2 agonists

The invention relates to compounds of formula (1) and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such derivatives. The compounds according to the present invention are useful in

Compounds for the treatment of diseases

The invention relates to compounds of formula (1) and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such derivatives. The compounds according to the present invention are useful in numerous diseases, disorders and conditions, in particular inflammatory, allergic and respiratory diseases, disorders and conditions.

2-(6-AMINO-PYRIDIN-3-YL)-2-HYDROXYETHYLAMINE DERIVATIVES AS BETA 2-ADRENOCEPTORS AGONISTS

The invention relates to compounds of formula (1) and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such derivatives. The compounds according to the present invention are useful in